2671 Results

People

  1. Schwartz
    Schwartz
  2. Do
    Do
  3. Ginsberg
    Ginsberg
  4. Gollub
    Gollub
  5. Hricak
    Hricak
  6. Gonen
    Gonen
  7. Jarnagin
    Jarnagin
  8. Akin
    Akin
  9. Plodkowski
    Plodkowski
  10. Morris
    Morris

Groups

  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)
  7. Molecular Imaging and Therapy Service (649)
  8. Biostatistics Service (647)
  9. GSK Faculty (643)
  10. Department of Pathology and Laboratory Medicine (537)
  1. "Body Imaging Service"
Formats
  1. Journal Article (1718)
  2. Meeting Abstract (519)
  3. Review (163)
  4. Book Section (128)
  5. Conference Paper (43)
  6. Editorial (35)
  7. Guidelines (29)
  8. Miscellaneous (16)
  9. Correspondence (11)
  10. Book Whole (5)
  11. Research Letter (4)
Groups
  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)

More Groups

People
  1. Lawrence Schwartz (306)
  2. Oguz Akin (264)
  3. Kinh Gian Do (256)
  4. Michelle Ginsberg (235)
  5. Marc Gollub (208)
  6. Hedvig Hricak (158)

More People

Years
  1. 2025 (69)
  2. 2024 (169)
  3. 2023 (220)
  4. 2022 (200)
  5. 2021 (189)
  6. 2020 (165)

More Years

Publications
  1. Journal of Clinical Oncology (322)
  2. American Journal of Roentgenology (147)
  3. Radiology (122)
  4. Abdominal Radiology (84)
  5. European Radiology (67)
  6. Clinical Cancer Research (65)

More Publications

Publishers
  1. Springer (359)
  2. American Society of Clinical Oncology (346)
  3. Elsevier Inc. (316)
  4. American Roentgen Ray Society (147)
  5. Radiological Society of North America, Inc. (140)
  6. Elsevier Science, Inc. (128)

More Publishers

Results (2671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P. K.; Srikakulum, A.; Ahn, L. S. H.; Plodkowski, A. J.; Ng, K. K.; McFarland, D.; Fiore, J. J.; Iqbal, A.; Eng, J.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK228
    Meeting Abstract

    Paik, P. K.; Qeriqi, B.; Ahn, L. S. H.; Ginsberg, M. S.; Tandon, N.; McFarland, D.; Doyle, L. A.; de Stanchina, E.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • ADI-PEG 20 and FOLFOX6: A phase 1 study in pts (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Do, R. K. G.; Hollywood, E.; Uhlitskykh, K.; Valentino, E.; Wan, P. J.; Hamilton, C. R.; Frick, J.; Feng, X.; Johnston, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Kelley, R. K.; Tan, B. R.; Iobst, E.; Boussayoud, C.; Muenkel, K. E.; Do, R. K. G.; Chou, J. F.; Capanu, M.; Ruiz, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Erinjeri, J. P.; Tan, B. R.; Reiss, K. A.; Mody, K.; Khalil, D.; Yarmohammadi, H.; Nadolski, G.; Giardina, J. D.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save